Tianmu Pharmaceutical's Controlling Shareholder Plans to Transfer 20% Stake via Public Solicitation

证券时报··Read original
3▲0 ▼0Impact / 5
Summary · why it matters

Tianmu Pharmaceutical announced that its controlling shareholder, Huilong Huaze, plans to transfer 24.3558 million unrestricted tradable shares, representing 20% of the company's total share capital, through a negotiated transfer by publicly soliciting a transferee. The transfer price will be no less than 22 yuan per share. Huilong Huaze currently holds a 29.99% stake in the company. If this transfer is completed, the company's controlling shareholder and actual controller may change.

Impact on assets 1

Others▲

Off-coverage companies 1

汇隆华泽i
Private▼ NegativeCapitalrelevance

Huilong Huaze plans to sell 20% stake, reducing its ownership from 29.99% to about 10%.